Trinity Biotech plc TRIB
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$7.51$7.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -30.18% | -31.64% | 18.09% | 3.24% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -30.18% | -31.64% | 18.09% | 3.24% | |
| Cost of Revenue | -34.66% | -38.49% | 23.91% | -5.32% | |
| Gross Profit | -20.07% | -19.55% | 6.79% | 24.02% | |
| SG&A Expenses | -30.89% | 8.64% | 20.64% | -15.15% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -200.60% | -- | -- | -- | |
| Total Operating Expenses | -46.20% | -20.99% | 33.79% | -9.42% | |
| Operating Income | 83.69% | -80.14% | -94.21% | 50.69% | |
| Income Before Tax | -11.73% | 17.64% | -186.96% | 26.22% | |
| Income Tax Expenses | -129.74% | 324.43% | 19,600.00% | -115.77% | |
| Earnings from Continuing Operations | -6.68% | 11.69% | -197.75% | 29.18% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -3.07% | 11.69% | -208.16% | 29.19% | |
| EBIT | 83.69% | -80.14% | -94.21% | 50.69% | |
| EBITDA | 87.73% | -54.95% | -109.78% | 62.05% | |
| EPS Basic | 26.96% | 55.14% | -78.15% | 47.74% | |
| Normalized Basic EPS | 75.07% | 42.17% | -- | -- | |
| EPS Diluted | 22.25% | 43.97% | -77.78% | 47.74% | |
| Normalized Diluted EPS | 75.07% | 42.17% | -- | -- | |
| Average Basic Shares Outstanding | 41.11% | 96.86% | 72.99% | 35.50% | |
| Average Diluted Shares Outstanding | 42.86% | 100.00% | 75.00% | 35.52% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |